corpus.blog
42,923 blogs · 5,458,805 posts Claim your blog
Record · corpus.blog/posts/01a0fff3-44ce-724f-b409-3989ae67a1cf

On Modality Commoditization

centuryofbio.com · published 16 March 2025

A record is what was published and who pointed at it. The text of the post is not held here: read it at the source, or at its Wayback capture.

Read the post at centuryofbio.com Wayback capture
2blogs citing
First cited
16 Mar 2025
Most recent
3 Aug 2025
Rank this month
not ranked
External links
92
Words captured
6,519

Cited by

Blog
In the post
Date
blog.jacobtrefethen.com
AI will not suddenly lead to an Alzheimer’s cure Read at the source ↗
3 Aug 2025
blog.jacobtrefethen.com
Science writing from the last two years that stuck with me Read at the source ↗
10 Jun 2025
Nintil
Links (86) Read at the source ↗
16 Mar 2025

Links from this post

Link
Host
https://substackcdn.com/image/fetch/$s_!lFXO!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F1909180e-8c37-4393-97af-0ff35ed9064b_1232x928.png
substackcdn.com
https://a.co/d/fqwiQCh
a.co
https://medium.com/the-biotech-social-contract/kolchinsky-tbsc-1-dafc2fe803e5
medium.com
https://www.statnews.com/2024/09/08/summit-therapeutics-ivonescimab-lung-cancer-merck-keytruda-results/
statnews.com
https://www.prnewswire.com/news-releases/akeso-inc-announces-collaboration-and-license-agreement-for-up-to-us5-billion-with-summit-therapeutics-to-accelerate-global-development-and-commercialization-of-its-breakthrough-bispecific-antibody-ivonescimab-pd-1vegf-301695787.html
prnewswire.com
https://www.biopharmadive.com/news/merck-lanova-pd1-vegf-bispecific-cancer-drug-deal/732906/
biopharmadive.com
https://www.reuters.com/technology/artificial-intelligence/what-is-deepseek-why-is-it-disrupting-ai-sector-2025-01-27/
reuters.com
https://www.wsj.com/health/pharma/the-drug-industry-is-having-its-own-deepseek-moment-68589d70
wsj.com
https://www.biopharmadive.com/news/merck-hansoh-obesity-license-deal-oral-glp-1/735884/
biopharmadive.com
https://www.statnews.com/2025/02/13/biotech-industry-sentiment-crispr-medicines-fda/
statnews.com
https://x.com/davidycli/status/1875043192330224119
x.com
https://timmermanreport.com/2025/01/china-is-here-to-stay-as-a-leader-on-the-global-biotech-stage/
timmermanreport.com
https://www.bloomberg.com/news/articles/2024-12-02/big-pharma-s-bet-on-china-biotech-is-a-rare-trade-bright-spot
bloomberg.com
Will all our drugs come from China? Read at the source ↗
atelfo.github.io
https://substackcdn.com/image/fetch/$s_!Im7Y!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fcd8a370d-1ec0-43ac-a63f-e684b321d7f7_1200x1600.png
substackcdn.com
https://substackcdn.com/image/fetch/$s_!CNUy!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F0383c3b3-9e58-4bf6-9865-75ea221fb242_2159x882.png
substackcdn.com
https://doi.org/10.1038/s41587-024-02166-7
doi.org
https://substackcdn.com/image/fetch/$s_!zgiB!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Ffa7e56e3-b7b6-4940-a59b-e210f2c24598_400x527.jpeg
substackcdn.com
https://doi.org/10.1126/science.6691156
doi.org
https://www.forbes.com/1999/01/14/mu3.html
forbes.com
https://en.wikipedia.org/wiki/Monoclonal_antibody
en.wikipedia.org
https://en.wikipedia.org/wiki/Gartner_hype_cycle
en.wikipedia.org
https://substackcdn.com/image/fetch/$s_!uLId!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F5a560e82-9d62-4ea9-a310-19adeb095601_1024x682.png
substackcdn.com
https://doi.org/10.1038/nbt0697-553
doi.org
https://substackcdn.com/image/fetch/$s_!4xkD!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F6b62fc43-c119-465b-b497-ca5b36c747cb_1644x796.png
substackcdn.com
https://adimab.com/partnering/
adimab.com
https://insights.citeline.com/SC092707/Private-Adimab-Breaks-1-Billion-Valuation-Offers-VCs-Liquidity-Through-100-Million-Secondary/
insights.citeline.com
https://fjbio.com/
fjbio.com
https://www.omniab.com/
omniab.com
https://www.ablexis.com/
ablexis.com
https://www.specifica.bio/
specifica.bio
https://www.creative-biolabs.com/
creative-biolabs.com
https://www.twistbioscience.com/twist-biopharma-solutions
twistbioscience.com
https://alloytx.com/
alloytx.com
https://a.co/d/3oMywBi
a.co
https://doi.org/10.1038/d41573-023-00063-3
doi.org
https://doi.org/10.1038/nrd1203
doi.org
https://substackcdn.com/image/fetch/$s_!8oTr!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F66888ca2-4e43-43da-8820-607fe172934d_600x453.jpeg
substackcdn.com
https://substackcdn.com/image/fetch/$s_!Qy2e!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fed8548c4-ec14-4364-98ca-2b4e144da006_767x701.jpeg
substackcdn.com
https://www.science.org/content/blog-post/virtual-biotech-it-or-not
science.org
https://www.bioprocessintl.com/global-markets/wuxi-bio-grabs-larger-piece-of-the-bio-cdmo-pie
bioprocessintl.com
https://www.ppd.com/wp-content/uploads/2020/03/Regulatory-Focus-2018.05-China.pdf
ppd.com
https://substackcdn.com/image/fetch/$s_!QeWA!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fdf24e4a4-7b63-42b5-966c-46a7cd17c422_767x341.jpeg
substackcdn.com
https://substackcdn.com/image/fetch/$s_!mBJ3!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F182eb55d-8b48-4e83-bc81-a68f7fe8546e_1202x1112.png
substackcdn.com
https://x.com/bradloncar/status/1869354477486256539
x.com
https://www.investopedia.com/terms/c/calloption.asp
investopedia.com
https://www.fiercebiotech.com/biotech/new-ai-drug-discovery-powerhouse-xaira-rises-1b-funding
fiercebiotech.com
https://www.evolutionaryscale.ai/
evolutionaryscale.ai
https://www.profluent.bio/
profluent.bio
https://www.chaidiscovery.com/
chaidiscovery.com
https://www.latentlabs.com/
latentlabs.com
https://www.pillar.vc/venture-capital/investing-in-latent-labs/
pillar.vc
https://endpts.com/ex-deepmind-scientist-launches-ai-biotech-latent-labs-with-50m/
endpts.com
https://research.dimensioncap.com/p/moml-2024-open-notes
research.dimensioncap.com
https://www.moml.mit.edu/
moml.mit.edu
https://www.biocurate.com/resources/constructing-a-target-product-profile-industrys-perspective/
biocurate.com
https://www.biorxiv.org/content/10.1101/2024.03.14.585103v1
biorxiv.org
https://en.wikipedia.org/wiki/Single-domain_antibody
en.wikipedia.org
https://substackcdn.com/image/fetch/$s_!h3Hk!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F452f6f94-3e2e-43e5-8f3a-4621965ec9bb_1584x1494.png
substackcdn.com
https://endpts.com/in-biggest-ever-bet-on-using-ai-to-design-drugs-biotech-heavyweights-launch-xaira-with-1b-in-backing/
endpts.com
https://endpts.com/david-bakers-lab-shows-generative-ai-can-design-antibodies-but-are-they-good-enough-to-become-drugs/
endpts.com
https://x.com/_JosephWatson/status/1895530676361056761
x.com
https://www.biorxiv.org/content/10.1101/2024.03.14.585103v2
biorxiv.org
https://en.wikipedia.org/wiki/Single-chain_variable_fragment
en.wikipedia.org
https://doi.org/10.1038/s41467-020-19539-6
doi.org
https://arxiv.org/abs/2108.07258
arxiv.org
https://endpts.com/isomorphic-labs-ceo-demis-hassabis-bets-on-biotechs-ai-future/
endpts.com
https://doi.org/10.1038/s41586-024-07487-w
doi.org
https://www.biorxiv.org/content/10.1101/2024.10.10.615955v1
biorxiv.org
https://github.com/chaidiscovery/chai-lab
github.com
https://www.biorxiv.org/content/10.1101/2024.11.19.624167v1
biorxiv.org
https://substackcdn.com/image/fetch/$s_!M-sD!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F40f027ba-dbb0-4a5c-8d2d-640494ef1fc3_681x486.png
substackcdn.com
https://leadershipandbiotechnology.blogspot.com/2018/08/early-stage-biotech-value-creation_15.html
leadershipandbiotechnology.blogspot.com
https://www.davidyang.bio/p/why-was-glp-1-not-a-biotech-success
davidyang.bio
https://x.com/ElliotHershberg/status/1894449232394031530
x.com
https://doi.org/10.1016/j.cell.2024.11.015
doi.org
https://www.mckinsey.com/industries/life-sciences/our-insights/first-time-launchers-in-the-pharmaceutical-industry
mckinsey.com
https://7powers.com/
7powers.com
https://a.co/d/fRHvAMz
a.co
https://tyastunggal.com/p/7-powers-the-foundations-of-business
tyastunggal.com
https://biotechsuccess.com/the-pharmaceutical-industry-is-an-information-industry/
biotechsuccess.com
https://substackcdn.com/image/fetch/$s_!ksVX!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F9b02038c-f0ec-4d55-86f2-495cef480187_3752x1667.png
substackcdn.com
https://www.notboring.co/p/medicines-endgame
notboring.co
https://a.co/d/eSBw857
a.co
https://substackcdn.com/image/fetch/$s_!sTGb!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F7c12fdcd-a500-44a6-9200-54bbd279dbf8_986x1402.png
substackcdn.com
https://www.notboring.co/p/vertical-integrators
notboring.co
https://carta.com/learn/equity/liquidity-events/secondary-transactions/
carta.com
https://en.wikipedia.org/wiki/Diphtheria_antitoxin
en.wikipedia.org
https://www.the-scientist.com/will-wall-streets-love-affair-with-biotech-continue-60578
the-scientist.com
https://en.wikipedia.org/wiki/OpenEye_Scientific_Software
en.wikipedia.org
https://youtu.be/PEgk2v6KntY?si=aB82_SLYdAbbdrkw
youtu.be
https://enveda.com/
enveda.com
Elsewhere on centuryofbio.com (6)